#ai-stocks

#ai-stocks

Undoubtedly, widespread skepticism may keep the bull in check, as investors become just a bit more cautious with the basket of AI winners that have led the market so far this year. While the skeptics, bears, and doomers may be right to tilt more conservatively (think defensive dividend stocks) as we progress through September, I think most investors should not attempt to time the market.

Despite the hype surrounding artificial intelligence, C3.ai seems stuck in neutral, failing to capitalize on the sector's explosive growth. The old Wall Street adage, "buy the rumor, sell the news," doesn't quite fit here. With C3.ai, the strategy appears to be sell the rumor, sell the news, and, frankly, just sell the stock. The company's inability to turn AI enthusiasm into sales or profits, coupled with leadership turmoil, paints a grim picture for its future.

Artificial intelligence stocks have been all the rage in the stock market, with some of them producing generational returns in just a few years. Not everyone has enough time to research compelling AI stocks, but if you follow the money, you might discover a hidden goldmine. Executives have been loading up on popular AI stocks, but they have also been buying under-the-radar stocks. These are some of the top AI stocks that are attracting institutional investors.

Nebius Group expects an ARR of up to $1.1 billion for 2024, showcasing remarkable growth from $117.5 million previously, indicating its significant potential in the AI sector.

Insider selling at Nvidia reflects a normal routine, primarily for personal financial needs, with little impact on the company’s strong AI position.

After leading market gains last year, artificial intelligence (AI) stocks are at it again. Investors became more optimistic that President Trump's import tariffs won't represent as much of a headwind for companies as initially expected.

HP Inc is shifting its focus towards AI-infused products that can drive growth, despite its traditionally mature business model. Launching products like the EliteBook Ultra and OmniBook X, HP aims to tap into new tech opportunities.

Mark Cuban is determined to challenge the influence of pharmacy benefit managers in U.S. healthcare through his startup, Cost Plus Drugs, aiming for market disruption.

Cramer praised Palantir as a 'must-own' stock, highlighting its significant growth and the leadership of CEO Alex Karp as crucial for its success.

Agentic AI models, trained to use tools and access data, could redefine software, enhancing personalization through real-world actions and automation.

Alphabet has built a strong source of revenue through its 90% market share in search, generating billions from advertising as companies target their ideal audience.